Overexpression of the Class I-specific nuclear HDACs (HDAC1, HDAC2, and HDAC3) has been associated with poor prognosis in multiple myeloma [198] and in colorectal cancer where Class-I HDAC expression has been described as an independent prognostic factor [199]. The gene discussed is HDAC9; the disease is colorectal cancer.